BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28422189)

  • 1. Exome Analysis of Rare and Common Variants within the NOD Signaling Pathway.
    Andreoletti G; Shakhnovich V; Christenson K; Coelho T; Haggarty R; Afzal NA; Batra A; Petersen BS; Mort M; Beattie RM; Ennis S
    Sci Rep; 2017 Apr; 7():46454. PubMed ID: 28422189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes.
    Christodoulou K; Wiskin AE; Gibson J; Tapper W; Willis C; Afzal NA; Upstill-Goddard R; Holloway JW; Simpson MA; Beattie RM; Collins A; Ennis S
    Gut; 2013 Jul; 62(7):977-84. PubMed ID: 22543157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deleterious Genetic Variation Across the NOD Signaling Pathway Is Associated With Reduced NFKB Signaling Transcription and Upregulation of Alternative Inflammatory Transcripts in Pediatric Inflammatory Bowel Disease.
    Ashton JJ; Boukas K; Stafford IS; Cheng G; Haggarty R; Coelho TAF; Batra A; Afzal NA; Williams AP; Polak ME; Beattie RM; Ennis S
    Inflamm Bowel Dis; 2022 Jun; 28(6):912-922. PubMed ID: 34978330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Sequencing of Pediatric Patients Identifies Mutations in Monogenic Inflammatory Bowel Disease Genes that Translate to Distinct Clinical Phenotypes.
    Ashton JJ; Mossotto E; Stafford IS; Haggarty R; Coelho TAF; Batra A; Afzal NA; Mort M; Bunyan D; Beattie RM; Ennis S
    Clin Transl Gastroenterol; 2020 Feb; 11(2):e00129. PubMed ID: 32463623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous preterm birth: advances toward the discovery of genetic predisposition.
    Strauss JF; Romero R; Gomez-Lopez N; Haymond-Thornburg H; Modi BP; Teves ME; Pearson LN; York TP; Schenkein HA
    Am J Obstet Gynecol; 2018 Mar; 218(3):294-314.e2. PubMed ID: 29248470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome analysis of patients with concurrent pediatric inflammatory bowel disease and autoimmune disease.
    Andreoletti G; Ashton JJ; Coelho T; Willis C; Haggarty R; Gibson J; Holloway J; Batra A; Afzal NA; Beattie RM; Ennis S
    Inflamm Bowel Dis; 2015 Jun; 21(6):1229-36. PubMed ID: 25895113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.
    Schiff ER; Frampton M; Ben-Yosef N; Avila BE; Semplici F; Pontikos N; Bloom SL; McCartney SA; Vega R; Lovat LB; Wood E; Hart A; Israeli E; Crespi D; Furman MA; Mann S; Murray CD; Segal AW; Levine AP
    Hum Genet; 2018 Sep; 137(9):723-734. PubMed ID: 30167848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease.
    Chirieleison SM; Marsh RA; Kumar P; Rathkey JK; Dubyak GR; Abbott DW
    J Biol Chem; 2017 Jun; 292(23):9666-9679. PubMed ID: 28404814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare coding variants in genes encoding GABA
    May P; Girard S; Harrer M; Bobbili DR; Schubert J; Wolking S; Becker F; Lachance-Touchette P; Meloche C; Gravel M; Niturad CE; Knaus J; De Kovel C; Toliat M; Polvi A; Iacomino M; Guerrero-López R; Baulac S; Marini C; Thiele H; Altmüller J; Jabbari K; Ruppert AK; Jurkowski W; Lal D; Rusconi R; Cestèle S; Terragni B; Coombs ID; Reid CA; Striano P; Caglayan H; Siren A; Everett K; Møller RS; Hjalgrim H; Muhle H; Helbig I; Kunz WS; Weber YG; Weckhuysen S; Jonghe P; Sisodiya SM; Nabbout R; Franceschetti S; Coppola A; Vari MS; Kasteleijn-Nolst Trenité D; Baykan B; Ozbek U; Bebek N; Klein KM; Rosenow F; Nguyen DK; Dubeau F; Carmant L; Lortie A; Desbiens R; Clément JF; Cieuta-Walti C; Sills GJ; Auce P; Francis B; Johnson MR; Marson AG; Berghuis B; Sander JW; Avbersek A; McCormack M; Cavalleri GL; Delanty N; Depondt C; Krenn M; Zimprich F; Peter S; Nikanorova M; Kraaij R; van Rooij J; Balling R; Ikram MA; Uitterlinden AG; Avanzini G; Schorge S; Petrou S; Mantegazza M; Sander T; LeGuern E; Serratosa JM; Koeleman BPC; Palotie A; Lehesjoki AE; Nothnagel M; Nürnberg P; Maljevic S; Zara F; Cossette P; Krause R; Lerche H; ; ;
    Lancet Neurol; 2018 Aug; 17(8):699-708. PubMed ID: 30033060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.
    Kelsen JR; Dawany N; Moran CJ; Petersen BS; Sarmady M; Sasson A; Pauly-Hubbard H; Martinez A; Maurer K; Soong J; Rappaport E; Franke A; Keller A; Winter HS; Mamula P; Piccoli D; Artis D; Sonnenberg GF; Daly M; Sullivan KE; Baldassano RN; Devoto M
    Gastroenterology; 2015 Nov; 149(6):1415-24. PubMed ID: 26193622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants and pathways implicated in a pediatric inflammatory bowel disease cohort.
    Shaw KA; Cutler DJ; Okou D; Dodd A; Aronow BJ; Haberman Y; Stevens C; Walters TD; Griffiths A; Baldassano RN; Noe JD; Hyams JS; Crandall WV; Kirschner BS; Heyman MB; Snapper S; Guthery S; Dubinsky MC; Shapiro JM; Otley AR; Daly M; Denson LA; Kugathasan S; Zwick ME
    Genes Immun; 2019 Feb; 20(2):131-142. PubMed ID: 29593342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved anti-bacterial roles in zebrafish.
    Oehlers SH; Flores MV; Hall CJ; Swift S; Crosier KE; Crosier PS
    Dis Model Mech; 2011 Nov; 4(6):832-41. PubMed ID: 21729873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2.
    Bertrand MJ; Doiron K; Labbé K; Korneluk RG; Barker PA; Saleh M
    Immunity; 2009 Jun; 30(6):789-801. PubMed ID: 19464198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic profile of patients with early onset inflammatory bowel disease.
    Girardelli M; Basaldella F; Paolera SD; Vuch J; Tommasini A; Martelossi S; Crovella S; Bianco AM
    Gene; 2018 Mar; 645():18-29. PubMed ID: 29248579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease.
    Ghorpade DS; Sinha AY; Holla S; Singh V; Balaji KN
    J Biol Chem; 2013 Nov; 288(46):33037-48. PubMed ID: 24092752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A discrete ubiquitin-mediated network regulates the strength of NOD2 signaling.
    Tigno-Aranjuez JT; Bai X; Abbott DW
    Mol Cell Biol; 2013 Jan; 33(1):146-58. PubMed ID: 23109427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD.
    Hu S; Vich Vila A; Gacesa R; Collij V; Stevens C; Fu JM; Wong I; Talkowski ME; Rivas MA; Imhann F; Bolte L; van Dullemen H; Dijkstra G; Visschedijk MC; Festen EA; Xavier RJ; Fu J; Daly MJ; Wijmenga C; Zhernakova A; Kurilshikov A; Weersma RK
    Gut; 2021 Feb; 70(2):285-296. PubMed ID: 32651235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of Early Onset Crohn's Disease.
    Horowitz JE; Warner N; Staples J; Crowley E; Gosalia N; Murchie R; Van Hout C; Fiedler K; Welch G; King AK; Reid JG; Overton JD; Baras A; Shuldiner AR; Griffiths A; Gottesman O; Muise AM; Gonzaga-Jauregui C
    Sci Rep; 2021 Mar; 11(1):5595. PubMed ID: 33692434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel NOD2 Mutation in Early-Onset Inflammatory Bowel Phenotype.
    Girardelli M; Loganes C; Pin A; Stacul E; Decleva E; Vozzi D; Baj G; De Giacomo C; Tommasini A; Bianco AM
    Inflamm Bowel Dis; 2018 May; 24(6):1204-1212. PubMed ID: 29697845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.
    Serra EG; Schwerd T; Moutsianas L; Cavounidis A; Fachal L; Pandey S; Kammermeier J; Croft NM; Posovszky C; Rodrigues A; Russell RK; Barakat F; Auth MKH; Heuschkel R; Zilbauer M; Fyderek K; Braegger C; Travis SP; Satsangi J; Parkes M; Thapar N; Ferry H; Matte JC; Gilmour KC; Wedrychowicz A; Sullivan P; Moore C; Sambrook J; Ouwehand W; Roberts D; Danesh J; Baeumler TA; Fulga TA; Carrami EM; Ahmed A; Wilson R; Barrett JC; Elkadri A; Griffiths AM; ; ; ; ; ; ; Snapper SB; Shah N; Muise AM; Wilson DC; Uhlig HH; Anderson CA
    Nat Commun; 2020 Feb; 11(1):995. PubMed ID: 32081864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.